tiprankstipranks
Advertisement
Advertisement

EKF Diagnostics Tightens Free Float With Treasury Share Buyback

Story Highlights
  • EKF Diagnostics repurchased 213,000 shares into treasury, adjusting voting share capital.
  • Shares bought from Harwood-managed funds keep director Christopher Mills below 30% control.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
EKF Diagnostics Tightens Free Float With Treasury Share Buyback

Claim 30% Off TipRanks

EKF Diagnostics Holdings ( (GB:EKF) ) has shared an update.

EKF Diagnostics Holdings has repurchased 213,000 ordinary shares at 26 pence each, placing them into treasury and leaving 431,609,112 shares in issue with voting rights. The transaction, executed on AIM, forms part of the company’s ongoing share buyback activity and modestly reduces the free float while providing flexibility for capital management.

As part of the buyback, EKF acquired 63,000 shares from funds managed by Harwood to keep Non-Executive Director Christopher Mills’ aggregate indirect interest at around, but not above, 30% of voting rights. Mills now indirectly holds 127,277,000 shares, and the move helps maintain regulatory thresholds and governance stability for major shareholders and the wider investor base.

The most recent analyst rating on (GB:EKF) stock is a Hold with a £26.00 price target. To see the full list of analyst forecasts on EKF Diagnostics Holdings stock, see the GB:EKF Stock Forecast page.

Spark’s Take on GB:EKF Stock

According to Spark, TipRanks’ AI Analyst, GB:EKF is a Neutral.

EKF Diagnostics Holdings receives a score of 67, driven by strong financial performance and a positive earnings call. The company’s robust balance sheet and improved profitability are significant strengths. However, technical indicators suggest potential bearish momentum, and the valuation is moderate. The positive outlook from the earnings call, including strategic growth plans and a share buyback program, enhances the overall score.

To see Spark’s full report on GB:EKF stock, click here.

More about EKF Diagnostics Holdings

EKF Diagnostics Holdings is an AIM-listed global diagnostics business focused on point-of-care analysers in hematology and diabetes, as well as life sciences services that manufacture specialist enzymes and custom products for diagnostic, food, and industrial applications. Headquartered near Cardiff, the company operates five manufacturing sites across the U.S. and Germany and sells into more than 120 countries worldwide.

Average Trading Volume: 272,174

Technical Sentiment Signal: Hold

Current Market Cap: £109.3M

For an in-depth examination of EKF stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1